Related Experiment Videos
Verbal fluency facilitated by the cholinergic blocker, scopolamine
S Pompéia1, J M Rusted, H V Curran
1Department of Psychobiology, UNIFESP, São Paulo, Brazil.
Human Psychopharmacology
|October 31, 2002
Summary
Low doses of scopolamine (SP) enhance phonemic verbal fluency but not semantic fluency. This suggests distinct cognitive processes underlie these two types of word generation.
Area of Science:
- Cognitive Neuroscience
- Pharmacology
Background:
- Verbal fluency, a measure of executive function, involves generating words based on specific criteria.
- Scopolamine (SP), an anticholinergic drug, has been investigated for its effects on cognitive processes.
Purpose of the Study:
- To investigate the effects of low doses of scopolamine on phonemic and semantic verbal fluency.
- To determine if scopolamine influences word generation, clustering, or switching in verbal fluency tasks.
Main Methods:
- A double-blind, parallel-group study involving 36 participants.
- Administration of 0.6 mg or 1.2 mg of scopolamine (SP) or placebo.
- Assessment of verbal fluency measures, including word count, clustering, and switching, before and after drug administration.
Main Results:
- Low-dose scopolamine significantly increased phonemic verbal fluency.
- Semantic verbal fluency was not enhanced by scopolamine, though higher word frequencies were observed at 1.2 mg.
- Scopolamine did not impact clustering or switching abilities in verbal fluency tasks.
Conclusions:
- Phonemic verbal fluency may be facilitated by low doses of scopolamine.
- Phonemic and semantic verbal fluency appear to rely on distinct cognitive mechanisms.
- Further research is needed to elucidate the precise role of cholinergic systems in different aspects of verbal fluency.